15-48495575-G-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000138.5(FBN1):c.2433C>A(p.Cys811*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 33)
Consequence
FBN1
NM_000138.5 stop_gained
NM_000138.5 stop_gained
Scores
2
3
2
Clinical Significance
Conservation
PhyloP100: 0.374
Genes affected
FBN1 (HGNC:3603): (fibrillin 1) This gene encodes a member of the fibrillin family of proteins. The encoded preproprotein is proteolytically processed to generate two proteins including the extracellular matrix component fibrillin-1 and the protein hormone asprosin. Fibrillin-1 is an extracellular matrix glycoprotein that serves as a structural component of calcium-binding microfibrils. These microfibrils provide force-bearing structural support in elastic and nonelastic connective tissue throughout the body. Asprosin, secreted by white adipose tissue, has been shown to regulate glucose homeostasis. Mutations in this gene are associated with Marfan syndrome and the related MASS phenotype, as well as ectopia lentis syndrome, Weill-Marchesani syndrome, Shprintzen-Goldberg syndrome and neonatal progeroid syndrome. [provided by RefSeq, Apr 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 15-48495575-G-T is Pathogenic according to our data. Variant chr15-48495575-G-T is described in ClinVar as [Pathogenic]. Clinvar id is 36049.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBN1 | NM_000138.5 | c.2433C>A | p.Cys811* | stop_gained | 21/66 | ENST00000316623.10 | NP_000129.3 | |
FBN1 | NM_001406716.1 | c.2433C>A | p.Cys811* | stop_gained | 20/65 | NP_001393645.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBN1 | ENST00000316623.10 | c.2433C>A | p.Cys811* | stop_gained | 21/66 | 1 | NM_000138.5 | ENSP00000325527.5 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome Cov.: 32
GnomAD4 exome
Cov.:
32
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Clinical Genetics Laboratory, Skane University Hospital Lund | May 04, 2023 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | May 18, 2017 | The C811X pathogenic variant in the FBN1 gene has been previously reported in association with Marfan syndrome (Hung et al., 2009; Wypasek et al., 2013). Hung et al. (2009) identified C811X in a Taiwanese patient or family fulfilling Ghent criteria for Marfan syndrome, although specific clinical information was not provided. Subsequently, Wypasek et al. (2013) reported C811X in a Polish female proband with Marfan syndrome. While the proband had several maternal relatives with clinical histories suspicious for Marfan syndrome, genetic testing of informative relatives was not performed at the time of publication (Wypasek et al., 2013). The C811X variant is classified in ClinVar as pathogenic or likely pathogenic by two other clinical laboratories (SCV000052362.1, SCV000319270.1; Landrum et al., 2016). C811X is predicted to cause loss of normal protein function either by protein truncation or nonsense-mediated mRNA decay. Multiple other nonsense variants in the FBN1 gene have been reported in Human Gene Mutation Database in association with FBN1-related disorders, including Marfan syndrome (Stenson et al., 2014). Furthermore, the C811X variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). - |
Marfan syndrome Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | Center for Medical Genetics Ghent, University of Ghent | Nov 07, 2017 | - - |
Familial thoracic aortic aneurysm and aortic dissection Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 07, 2020 | The p.C811* pathogenic mutation (also known as c.2433C>A), located in coding exon 20 of the FBN1 gene, results from a C to A substitution at nucleotide position 2433. This changes the amino acid from a cysteine to a stop codon within coding exon 20. In a study of Taiwanese patients with Marfan syndrome, this mutation was detected in an individual fulfilling Ghent criteria with cardiovascular, ocular, and dural manifestations; this variant was also reported in one individual from a Polish Marfan syndrome cohort (Hung CC et al. Ann. Hum. Genet., 2009 Nov;73:559-67; Wypasek E et al. Pol. Arch. Med. Wewn., 2013;123:646-7). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. - |
Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Feb 10, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Uncertain
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at